Renaissance Technologies - VYNE THERAPEUTICS INC ownership

VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 43 filers reported holding VYNE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of VYNE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$130
-99.9%
866,827
-6.7%
0.00%
Q3 2022$207,000
-43.3%
929,004
-1.1%
0.00%
Q2 2022$365,000
-41.8%
939,527
-2.6%
0.00%
-100.0%
Q1 2022$627,000
-32.1%
965,098
+6.7%
0.00%0.0%
Q4 2021$923,000
-46.7%
904,531
-27.3%
0.00%
-50.0%
Q3 2021$1,731,000
+58.7%
1,245,027
+300.4%
0.00%
+100.0%
Q2 2021$1,091,000310,9270.00%
Other shareholders
VYNE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
DSC Advisors, L.P. 2,670,000$1,038,0001.04%
DELTEC ASSET MANAGEMENT LLC 30,000$12,0000.00%
Tekla Capital Management LLC 135,395$53,0000.00%
Virtu Financial LLC 64,838$25,0000.00%
TWO SIGMA SECURITIES, LLC 127,844$50,0000.00%
STALEY CAPITAL ADVISERS INC 62,500$24,0000.00%
Beacon Pointe Advisors, LLC 75,000$28,0000.00%
Cetera Advisor Networks LLC 115,000$45,0000.00%
TOBIAS FINANCIAL ADVISORS, INC. 11,000$4,0000.00%
Russell Investments Group, Ltd. 3,375$1,0000.00%
View complete list of VYNE THERAPEUTICS INC shareholders